Dose intensification and molecular responses in patients with chronic lymphocytic leukaemia: A phase II single centre study

Bone Marrow Transplantation

Volumn 24, Issue 9, 1999, Pages 989-993

  Schey, S A ^a   Ahsan, G ^a   Jones, R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autologous blood cell transplantation; Molecular responses; Multiple myeloma

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PURINE ANTAGONIST;

ADULT; ARTICLE; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WHOLE BODY RADIATION;

EID: 0032715454     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702026     Document Type: Article

References (19)

1. Monteserrat E, Gomis F, Vallespi T et al. Presenting features and prognosis of chronic lymphocytic leukaemia in younger patients. Blood 1991; 78: 1545-1551.
2. Raphael B, Andersen JW, Silber R et al. Comparison of chlorambucil and prednisolone versus cyclophosphamide, vincristine and prednisolone as initial treatment for chronic lymphocytic leukaemia: long term follow-up of an Eastern Cooperative Oncology Group randomised clinical trial. J Clin Oncol 1991; 9: 770-776.
3. Robertson LE, Huh YO, Butler JJ et al. Response assessment in chronic lymphocytic leukaemia after fludarabine plus prednisolone: clinical pathologic, immunophenotypic and molecular analysis. Blood 1992; 80: 29-36.
4. Keating MJ, Kantarjian H, Talpaz M et al. Fludarabine; a new agent with major activity against chronic lymphocytic leukaemia. Blood 1989; 74: 19-25.
5. Esteve J, Villamor N, Colomer D et al. Haemopoietic stem cell transplantation in chronic lymphocytic leukaemia: a report of 12 patients from a single institution. Ann Oncol 1998; 9: 167-172.
6. Dreger P, Schmitz N. The role of stem cell transplantation in the treatment of chronic lymphocytic leukaemia. Leukemia 1997; 11 (Suppl. 2): S42-45.
7. Flinn IW, Vogelsang G. Bone marrow transplantation for chronic lymphocytic leukaemia. Semin Oncol 1998; 25: 60-64.
8. International Workshop on Chronic Lymphocytic Leukaemia. Chronic lymphocytic leukaemia: recommendations for diagnosis, staging and response criteria. Ann Intern Med 1989; 110: 236-238.
9. Rai RK, Peterson B, Elias I et al. A randomised comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukaemia: A CALGB, SWOG, CTG/NCI-C and ECOG Intergroup Study. Blood 1996; 88 (Suppl.): 141a.
10. Johnson S, Smith AG, Loffler H et al. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin and prednisolone (CAP) for treatment of advanced stage chronic lymphocytic leukaemia. Lancet 1996; 347: 1432-1438.
11. Jacksic B, Delmer A, Brugiatelli M et al. Interim analysis of a randomised EORTC study comparing high dose chlorambucil vs fludarabine in untreated B-cell chronic lymphocytic leukaemia. VII IWCLL, May 2-4 1997, Crete, Greece, Abstr. 64.
12. Martinez C, Martino R, Brunet S et al. Allogeneic stem cell transplantation for advanced low grade lymphoproliferative disorders: report of six cases. Haematologica 1996; 81: 330-334.
13. Khouri IF, Przepiorka D, van Besien K et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol 1997; 97: 466-473.
14. Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukaemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann Int Med 1996; 124: 311-315.
15. Gribben JG. Bone marrow transplantation for low grade B-cell malignancies. Curr Opin Oncol 1997; 9: 117-121.
16. de Lima M, O'Brien S, Lerner S, Keating MJ. Chronic lymphocytic leukaemia in the young patient. Semin Oncol 1998; 25: 107-116.
17. Brenner MK, Rill DR, Holladay MS et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993; 342: 1134-1137.
18. Robertson LE, Huh YO, Butler JJ et al. Response assessment in chronic lymphocytic leukaemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic and molecular analysis. Blood 1992; 80: 29-36.
19. Catovsky D, Fooks J, Richards S. Working Party on Leukaemia in Adults. Prognostic factors in chronic lymphocytic leukaemia; the importance of age, sex and response to treatment in survival. A report from the MRC CLL1 trial. Br J Haematol 1989; 72: 141-149.